The global burden of malaria remains substantial, exacerbated by the progressive emergence of resistance to frontline antimalarial therapies.
Plasmodium falciparum
, the most lethal malaria parasite, has developed reduced susceptibility to artemisinin-based combination therapies and several partner drugs, underscor...
PAUL CHIDOKA CHIKEZIE, F. O. Ohiagu, R. Ekeanyanwu et al.· Academia Drug Development an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.